|
1
|
Xia ZP, Sun L, Chen X, Pineda G, Jiang X,
Adhikari A, Zeng W and Chen ZJ: Direct activation of protein
kinases by unanchored polyubiquitin chains. Nature. 461:114–119.
2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Shim JH, Xiao C, Paschal AE, Bailey ST,
Rao P, Hayden MS, Lee KY, Bussey C, Steckel M, Tanaka N, et al:
TAK1, but not TAB1 or TAB2, plays an essential role in multiple
signaling pathways in vivo. Genes Dev. 19:2668–2681.
2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Thienpont B, Zhang L, Postma AV, Breckpot
J, Tranchevent LC, Van Loo P, Møllgård K, Tommerup N, Bache I,
Tümer Z, et al: Haploinsufficiency of TAB2 causes congenital heart
defects in humans. Am J Hum Genet. 86:839–849. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chen J, Yuan H, Xie K, Wang X, Tan L, Zou
Y, Yang Y, Pan L, Xiao J, Chen G and Liu Y: A novel TAB2 nonsense
mutation (p.S149X) causing autosomal dominant congenital heart
defects: A case report of a Chinese family. BMC Cardiovasc Disord.
20(27)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ackerman JP, Smestad JA, Tester DJ,
Qureshi MY, Crabb BA, Mendelsohn NJ and Ackerman MJ: Whole exome
sequencing, familial genomic triangulation, and systems biology
converge to identify a novel nonsense mutation in TAB2-encoded
TGF-beta activated kinase 1 in a child with polyvalvular Syndrome.
Congenit Heart Dis. 11:452–461. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ritelli M, Morlino S, Giacopuzzi E,
Bernardini L, Torres B, Santoro G, Ravasio V, Chiarelli N,
D'Angelantonio D, Novelli A, et al: A recognizable systemic
connective tissue disorder with polyvalvular heart dystrophy and
dysmorphism associated with TAB2 mutations. Clin Genet. 93:126–133.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li H and Durbin R: Fast and accurate short
read alignment with Burrows-Wheeler transform. Bioinformatics.
25:1754–1760. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
McKenna A, Hanna M, Banks E, Sivachenko A,
Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly
M and DePristo MA: The Genome Analysis Toolkit: A MapReduce
framework for analyzing next-generation DNA sequencing data. Genome
Res. 20:1297–1303. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American College
of Medical Genetics and Genomics and the Association for Molecular
Pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Westphal DS, Mastantuono E, Seidel H,
Riedhammer KM, Hahn A, Vill K and Wagner M: There is more to it
than just congenital heart defects-The phenotypic spectrum of
TAB2-related syndrome. Gene. 814(146167)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Engwerda A, Leenders EKSM, Frentz B,
Terhal PA, Löhner K, de Vries BBA, Dijkhuizen T, Vos YJ, Rinne T,
van den Berg MP, et al: TAB2 deletions and variants cause a highly
recognisable syndrome with mitral valve disease, cardiomyopathy,
short stature and hypermobility. Eur J Hum Genet. 29:1669–1676.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Permanyer E, Laurie S, Blasco-Lucas A,
Maldonado G, Amador-Catalan A, Ferrer-Curriu G, Fuste B, Perez ML,
Gonzalez-Alujas T, Beltran S, et al: A single nucleotide deletion
resulting in a frameshift in exon 4 of TAB2 is associated with a
polyvalular syndrome. Eur J Med Genet. 63(103854)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vasilescu C, Ojala TH, Brilhante V, Ojanen
S, Hinterding HM, Palin E, Alastalo TP, Koskenvuo J, Hiippala A,
Jokinen E, et al: Genetic basis of severe childhood-onset
cardiomyopathies. J Am Coll Cardiol. 72:2324–2338. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Caulfield TR, Richter JE Jr, Brown EE,
Mohammad AN, Judge DP and Atwal PS: Protein molecular modeling
techniques investigating novel TAB2 variant R347X causing
cardiomyopathy and congenital heart defects in multigenerational
family. Mol Genet Genomic Med. 6:666–672. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Liu H, Giguet-Valard AG, Simonet T,
Szenker-Ravi E, Lambert L, Vincent-Delorme C, Scheidecker S, Fradin
M, Morice-Picard F, Naudion S, et al: Next-generation sequencing in
a series of 80 fetuses with complex cardiac malformations and/or
heterotaxy. Hum Mutat. 41:2167–2178. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hanson J, Brezavar D, Hughes S,
Amudhavalli S, Fleming E, Zhou D, Alaimo JT and Bonnen PE: TAB2
variants cause cardiovascular heart disease, connective tissue
disorder, and developmental delay. Clin Genet. 101:214–220.
2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cheng A, Dinulos MBP, Neufeld-Kaiser W,
Rosenfeld J, Kyriss M, Madan-Khetarpal S, Risheg H, Byers PH and
Liu YJ: 6q25.1 (TAB2) microdeletion syndrome: Congenital heart
defects and cardiomyopathy. Am J Med Genet A. 173:1848–1857.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yin H, Guo X, Chen Y, Zeng Y, Mo X, Hong
S, He H, Li J, Steinmetz R and Liu Q: TAB2 deficiency induces
dilated cardiomyopathy by promoting RIPK1-dependent apoptosis and
necroptosis. J Clin Invest. 132(e152297)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Mifflin L, Ofengeim D and Yuan J:
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic
target. Nat Rev Drug Discov. 19:553–571. 2020.PubMed/NCBI View Article : Google Scholar
|
